<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-109151</identifier>
<setSpec>1699-8855</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Concurrent thymic squamous cell carcinoma and disseminated intravascular large B-cell lymphoma. A previously unreported association</dc:title>
<dc:description xml:lang="en">The incidence of extrathymic malignancies in patients with thymoma is significantly higher than in the general population. Non-Hodgkin lymphoma represents the most commonly associated tumor type. We report the concurrence of primary thymic squamous cell carcinoma and disseminated intravascular large B-cell lymphoma (IVL) in a 78-year-old man characterized by a rapidly fatal clinical course. To our knowledge, this is the first time that such an association is reported. Due to its rarity and the multiplicity of presentations, it is very difficult to diagnose this type of extranodal lymphoma antemortem. The intravascular lymphoma should be included in the differential diagnosis when a patient presents signs of a systemic disease and marked elevation of serum LDH. In this case the lymphoma may have been developed as a result of defective immunologic surveillance or impaired immunoregulation caused by the thymic carcinoma. In our case as in some other cases of IVL, diagnosis could only be conclusively confirmed on autopsy(AU)</dc:description>
<dc:creator>Val-Bernal, J. Fernando</dc:creator>
<dc:creator>Mayorga, Marta</dc:creator>
<dc:creator>Mariuxi Bermúdez, G</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La incidencia de tumores malignos extratímicos en pacientes con timoma es significantivamente más alta que en la población general. El linfoma no Hodgkin es la neoplasia más comúnmente asociada. En esta revisión, informamos la concurrencia de un carcinoma epidermoide tímico y un linfoma intravascular de células B grandes diseminado, caracterizado por presentación clínica rápidamente progresiva y fatal, en un hombre de 78 a&#152;nos. Este caso constituye la primera asociación informada entre ambas neoplasias. Debido a su rareza y a la multiplicidad de presentaciones, es muy difícil diagnosticar este tipo de linfoma antemortem, por lo que debería ser incluido en el diagnóstico diferencial de todo paciente que presente enfermedad sistémica y elevación marcada de la deshidrogenada láctica sérica. En el presente caso pensamos que el linfoma pudiera haberse desarrollado como resultado de un defecto en la vigilancia inmunológica o una alteración de la inmunorregulación causada por el carcinoma tímico. En casos como el actual la autopsia es el único método de diagnostico seguro(AU)</dc:description>
<dc:source>Rev. esp. patol;46(1): 45-50, ene.-mar.2013. ilus</dc:source>
<dc:identifier>ibc-109151</dc:identifier>
<dc:title xml:lang="es">Carcinoma epidermoide tímico y linfoma intravascular de células B grandes diseminado. Una asociación no informada</dc:title>
<dc:subject>^d2337^s22053</dc:subject>
<dc:subject>^d14332^s22053</dc:subject>
<dc:subject>^d14332^s22016</dc:subject>
<dc:subject>^d14341^s22053</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d23164^s22053</dc:subject>
<dc:subject>^d3965</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d8650^s22053</dc:subject>
<dc:subject>^d8647^s22016</dc:subject>
<dc:subject>^d8647^s22012</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d2337^s22016</dc:subject>
<dc:subject>^d8650^s29166</dc:subject>
<dc:subject>^d8647^s22053</dc:subject>
<dc:type>article</dc:type>
<dc:date>201303</dc:date>
</metadata>
</record>
</ibecs-document>
